NLS Financial Statements From 2010 to 2025

NLSPW Stock  USD 0.01  0  7.69%   
NLS Pharmaceutics financial statements provide useful quarterly and yearly information to potential NLS Pharmaceutics AG investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on NLS Pharmaceutics financial statements helps investors assess NLS Pharmaceutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting NLS Pharmaceutics' valuation are summarized below:
Market Capitalization
37.8 M
There are over one hundred nineteen available fundamental ratios for NLS Pharmaceutics, which can be analyzed over time and compared to other ratios. All traders should should check NLS Pharmaceutics' last-minute fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to drop to about 660 M in 2025. Enterprise Value is likely to drop to about 908 M in 2025
Check NLS Pharmaceutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NLS Pharmaceutics' main balance sheet or income statement drivers, such as Interest Income of 681.3 K, Depreciation And Amortization of 9.8 K or Interest Expense of 124.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NLS financial statements analysis is a perfect complement when working with NLS Pharmaceutics Valuation or Volatility modules.
  
Check out the analysis of NLS Pharmaceutics Correlation against competitors.

NLS Pharmaceutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.3 M2.1 M2.7 M
Pretty Stable
Short and Long Term Debt Total1.4 M1.5 M5.5 M
Slightly volatile
Other Current LiabilitiesM1.9 M779.7 K
Slightly volatile
Total Current Liabilities9.6 M9.1 M3.4 M
Slightly volatile
Accounts Payable2.7 M5.3 M1.8 M
Slightly volatile
Cash980.7 KM2.2 M
Very volatile
Non Current Assets Total20.2 K21.2 K102.3 K
Pretty Stable
Non Currrent Assets Other14.4 K15.2 K87 K
Pretty Stable
Long Term Debt268 K282.1 KM
Slightly volatile
Cash And Short Term Investments980.7 KM2.2 M
Very volatile
Common Stock Shares Outstanding46.1 M43.9 M17.8 M
Slightly volatile
Liabilities And Stockholders Equity3.3 M2.1 M2.7 M
Pretty Stable
Non Current Liabilities Total3.4 M2.5 M6.2 M
Slightly volatile
Capital Surpluse17.1 M23.7 M14 M
Slightly volatile
Other Current Assets1.1 M1.1 M279.1 K
Slightly volatile
Other Stockholder Equity35.5 M70.1 M24.4 M
Slightly volatile
Total Liabilities6.6 M9.6 MM
Slightly volatile
Total Current Assets3.1 M2.1 M2.6 M
Pretty Stable
Common Stock885.6 K843.4 K307.9 K
Slightly volatile
Net Receivables9.1 K9.6 K20.6 K
Slightly volatile
Short and Long Term Debt1.3 M1.9 M1.1 M
Slightly volatile
Capital Stock885.6 K843.4 K310.5 K
Slightly volatile
Short Term Debt1.8 M1.9 M157.2 M
Pretty Stable
Other Assets0.860.9162.6 K
Slightly volatile

NLS Pharmaceutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income681.3 K505.9 K782 K
Slightly volatile
Interest Expense124.1 K130.6 K613.4 K
Slightly volatile
Selling General Administrative7.1 M6.8 M2.3 M
Slightly volatile
Other Operating Expenses8.6 M13.6 M7.3 M
Slightly volatile
Research Development4.5 M6.8 M4.4 M
Pretty Stable
Total Operating Expenses8.6 M13.6 M7.3 M
Slightly volatile
Selling And Marketing Expenses9.8 K10.3 K2.5 M
Pretty Stable
Cost Of Revenue12.1 K13.1 K10.5 K
Slightly volatile

NLS Pharmaceutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock2.6 M2.9 M3.2 M
Slightly volatile
Begin Period Cash Flow10.8 M10.3 M2.8 M
Slightly volatile
Total Cash From Financing Activities1.8 M1.9 M6.1 M
Very volatile
End Period Cash Flow980.7 KM2.2 M
Very volatile
Depreciation9.8 K10.3 K49.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables1.6 M1.8 M1.4 M
Slightly volatile
Capex To Depreciation4.0E-44.0E-42.9523
Slightly volatile
Payables Turnover0.00480.00280.0053
Slightly volatile
Cash Per Share0.02570.0272.8268
Very volatile
Days Payables Outstanding76.6 K133.4 K74.5 K
Slightly volatile
Income Quality0.520.720.7173
Pretty Stable
Current Ratio0.20.211.5192
Slightly volatile
Graham Number1.411.48407
Very volatile
Average Receivables29.8 K50.5 K32.9 K
Slightly volatile
Interest Debt Per Share0.05090.05362.8 K
Very volatile
Debt To Assets0.971.025.4551
Very volatile
Days Of Payables Outstanding76.6 K133.4 K74.5 K
Slightly volatile
Ebt Per Ebit1.31.191.179
Very volatile
Quick Ratio0.20.211.5218
Slightly volatile
Cash Ratio0.09690.11.434
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9836
Slightly volatile
Debt Ratio0.971.025.4551
Very volatile

NLS Pharmaceutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap660 M808.1 MB
Slightly volatile
Enterprise Value908 MB1.1 B
Slightly volatile

NLS Fundamental Market Drivers

Cash And Short Term Investments897.7 K

About NLS Pharmaceutics Financial Statements

NLS Pharmaceutics investors use historical fundamental indicators, such as NLS Pharmaceutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NLS Pharmaceutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.9 B1.8 B
Cost Of Revenue13.1 K12.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NLS Stock Analysis

When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.